# OnCo record radioactive-iodine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/radioactive-iodine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "radioactive-iodine" ;
  schema:name "Radioactive iodine (I-131)"@en ;
  schema:description "The original targeted radiotherapy: thyroid cells soak up iodine, so radioactive iodine destroys leftover thyroid tissue and metastases while sparing everything else."@en ;
  schema:url <https://onco.cc/drugs/radioactive-iodine/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Iodine-131> ;
  owl:sameAs <http://www.wikidata.org/entity/Q927316> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Radioactive%20iodine>, <https://www.uniprot.org/uniprotkb/Q92911/entry> ;
  onco:status "approved" ;
  onco:modality "Radiopharmaceutical (beta/gamma emitter, natural uptake)" ;
  schema:alternateName "Sodium iodide I-131" ;
  onco:approval "US 1951: Hyperthyroidism and thyroid carcinoma (first radiopharmaceutical approval)" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/radioiodine-therapy/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:terms <https://onco.cc/terms/theranostics/>, <https://onco.cc/terms/rai-refractory/>, <https://onco.cc/terms/low-risk-dtc/>, <https://onco.cc/terms/radioiodine-term/> ;
  onco:trials <https://onco.cc/trials/hilo/>, <https://onco.cc/trials/estimabl2/>, <https://onco.cc/trials/ion-trial/> .